武田薬品工業株式会社
Summary
武田薬品工業株式会社 is registered in Japan and entered in the “Companies Registration” under number 1200-01-077461. Its legal form is 株式会社 (株) – joint-stock company (Japan). 武田薬品工業株式会社 is the ultimate parent of a group of 11 subsidiaries in 9 countries, as reported to GLEIF. GLEIF gives this reason: the entity is controlled by one or more natural persons without an intermediate legal entity. GLEIF does not name them, and neither does AssetCensus. It has 8 direct subsidiaries in GLEIF data; 2 of them have a lapsed LEI. The LEI was first issued on 15 Nov 2013 and the record was last updated on 6 Nov 2025; the next renewal is due by 2 Dec 2026. GLEIF's ISIN mapping lists 33 ISINs for this LEI.
Written from GLEIF data using fixed, reviewed sentence templates.
Data-quality notes (AssetCensus analysis)
No data-quality notes for this entity in this data release.
Company details
| Legal form | 株式会社 (株) joint-stock company (Japan) |
|---|---|
| Register | Companies Registration · Register website |
| Registration number | 1200-01-077461 |
| Registration authority | Legal Affairs Bureau |
| Jurisdiction | Japan |
| Registered address | 中央区道修町四丁目１番１号, 541-0045 大阪, Japan |
| Category | company or other legal entity |
| Status | active |
| Founded (per GLEIF) | 12 Jan 1925 |
| LEI | 549300ZLMVP4X0OGR454 |
| LEI status | active |
| LEI first issued | 15 Nov 2013 |
| LEI record last updated | 6 Nov 2025 |
| Next LEI renewal | 2 Dec 2026 |
| Corroboration of the LEI record | fully corroborated |
Group membership
Parent not reported to GLEIF
- Direct parent: the entity is controlled by one or more natural persons without an intermediate legal entity. GLEIF does not name them, and neither does AssetCensus.
- Ultimate parent: the entity is controlled by one or more natural persons without an intermediate legal entity. GLEIF does not name them, and neither does AssetCensus.
Direct subsidiaries (8)
- Baxalta Innovations GmbH Austria · Wien
- Takeda Manufacturing Austria AG Austria · Wien
- TAKEDA BELGIUM Belgium lapsed · Zaventem
- Takeda Pharmaceuticals International AG Switzerland · Zurich
- Takeda Pharmaceuticals Czech Republic s.r.o Czechia · Praha
- BioLife Plazma Hungary Korlátolt Felelősségű Társaság Hungary · Budapest
- TAKEDA PHARMACEUTICALS U.S.A., INC. United States lapsed · WILMINGTON
- TAKEDA U.S. FINANCING, INC. United States · WILMINGTON
ISINs mapped to this LEI (33)
JP3463000004 · JP346300AK65 · JP346300AMA6 · JP346300AQ69 · JP346300AR68 · JP346300BR67 · JP346300CR66 · US8740601062 · US8740602052 · US874060AD83
33 in the GLEIF–ANNA mapping file; first 10 shown. The file covers ISINs issued since the mapping started, not all securities.